Olaparib
Brand name: Lynparza
Rank #134 of 500 drugs by total cost
$121.1M
Total Cost
8,744
Total Claims
$121.1M
Total Cost
451
Prescribers
$14K
Cost per Claim
101
Beneficiaries
8,866
30-Day Fills
$268K
Avg Cost/Provider
19
Avg Claims/Provider
About Olaparib
Olaparib (sold as Lynparza) was prescribed 8,744 times by 451 Medicare Part D providers in 2023, costing the program $121.1M. At $14K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 131 | Pregabalin (Pregabalin) | $124.3M | 2,696,923 |
| 132 | Dronedarone Hcl (Multaq) | $123.4M | 98,156 |
| 133 | Brimonidine Tartrate/Timolol (Brimonidine Tartrate-Timolol) | $122.0M | 361,001 |
| 134 | Olaparib (Lynparza) | $121.1M | 8,744 |
| 135 | Empagliflozin/Metformin Hcl (Synjardy Xr) | $119.7M | 121,366 |
| 136 | Edaravone (Radicava Ors) | $119.6M | 8,588 |
| 137 | Insulin Regular, Human (Afrezza) | $119.4M | 143,017 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology